Mark A Rodrigues1,2, Neshika E Samarasekera1, Christine Lerpiniere1, Luke A Perry3, Tom J Moullaali1, James J M Loan1,4,5, Joanna M Wardlaw1,6,7, Rustam Al-Shahi Salman1. 1. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. 2. Department of Neuroradiology, NHS Lothian, Edinburgh, UK. 3. Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia. 4. Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK. 5. Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK. 6. UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK. 7. Row Fogo Centre for Research into Ageing and the Brain, University of Edinburgh, Edinburgh, UK.
Abstract
OBJECTIVE: A study was undertaken to assess whether cerebral small vessel disease (SVD) computed tomographic (CT) biomarkers are associated with long-term outcome after intracerebral hemorrhage. METHODS: We performed a prospective, community-based cohort study of adults diagnosed with spontaneous intracerebral hemorrhage between June 1, 2010 and May 31, 2013. A neuroradiologist rated the diagnostic brain CT for acute intracerebral hemorrhage features and SVD biomarkers. We used severity of white matter lucencies and cerebral atrophy, and the number of lacunes to calculate the CT SVD score. We assessed the association between CT SVD biomarkers and either death, or death or dependence (modified Rankin Scale scores = 4-6) 1 year after first-ever intracerebral hemorrhage using logistic regression, adjusting for known predictors of outcome. RESULTS: Within 1 year of intracerebral hemorrhage, 224 (56%) of 402 patients died. In separate models, 1-year death was associated with severe atrophy (adjusted odds ratio [aOR] = 2.54, 95% confidence interval [CI] = 1.44-4.49, p = 0.001) but not lacunes or severe white matter lucencies, and CT SVD sum score ≥ 1 (aOR = 2.50, 95% CI = 1.40-4.45, p = 0.002). Two hundred seventy-seven (73%) of 378 patients with modified Rankin Scale data were dead or dependent at 1 year. In separate models, 1-year death or dependence was associated with severe atrophy (aOR = 3.67, 95% CI = 1.71-7.89, p = 0.001) and severe white matter lucencies (aOR = 2.18, 95% CI = 1.06-4.51, p = 0.035) but not lacunes, and CT SVD sum score ≥ 1 (aOR = 2.81, 95% CI = 1.45-5.46, p = 0.002). INTERPRETATION: SVD biomarkers on the diagnostic brain CT are associated with 1-year death and dependence after intracerebral hemorrhage, independent of known predictors of outcome. ANN NEUROL 2021;89:266-279.
OBJECTIVE: A study was undertaken to assess whether cerebral small vessel disease (SVD) computed tomographic (CT) biomarkers are associated with long-term outcome after intracerebral hemorrhage. METHODS: We performed a prospective, community-based cohort study of adults diagnosed with spontaneous intracerebral hemorrhage between June 1, 2010 and May 31, 2013. A neuroradiologist rated the diagnostic brain CT for acute intracerebral hemorrhage features and SVD biomarkers. We used severity of white matter lucencies and cerebral atrophy, and the number of lacunes to calculate the CT SVD score. We assessed the association between CT SVD biomarkers and either death, or death or dependence (modified Rankin Scale scores = 4-6) 1 year after first-ever intracerebral hemorrhage using logistic regression, adjusting for known predictors of outcome. RESULTS: Within 1 year of intracerebral hemorrhage, 224 (56%) of 402 patients died. In separate models, 1-year death was associated with severe atrophy (adjusted odds ratio [aOR] = 2.54, 95% confidence interval [CI] = 1.44-4.49, p = 0.001) but not lacunes or severe white matter lucencies, and CT SVD sum score ≥ 1 (aOR = 2.50, 95% CI = 1.40-4.45, p = 0.002). Two hundred seventy-seven (73%) of 378 patients with modified Rankin Scale data were dead or dependent at 1 year. In separate models, 1-year death or dependence was associated with severe atrophy (aOR = 3.67, 95% CI = 1.71-7.89, p = 0.001) and severe white matter lucencies (aOR = 2.18, 95% CI = 1.06-4.51, p = 0.035) but not lacunes, and CT SVD sum score ≥ 1 (aOR = 2.81, 95% CI = 1.45-5.46, p = 0.002). INTERPRETATION: SVD biomarkers on the diagnostic brain CT are associated with 1-year death and dependence after intracerebral hemorrhage, independent of known predictors of outcome. ANN NEUROL 2021;89:266-279.
Authors: Lorenzo Rinaldo; Diane M Johnson; Roanna L Vine; Alejandro A Rabinstein; Giuseppe Lanzino Journal: J Neurosurg Date: 2018-08-10 Impact factor: 5.115
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Neshika Samarasekera; Arthur Fonville; Christine Lerpiniere; Andrew J Farrall; Joanna M Wardlaw; Philip M White; Colin Smith; Rustam Al-Shahi Salman Journal: Stroke Date: 2015-01-13 Impact factor: 7.914
Authors: Julie Staals; Tom Booth; Zoe Morris; Mark E Bastin; Alan J Gow; Janie Corley; Paul Redmond; John M Starr; Ian J Deary; Joanna M Wardlaw Journal: Neurobiol Aging Date: 2015-06-26 Impact factor: 4.673
Authors: Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans Journal: Lancet Neurol Date: 2013-08 Impact factor: 44.182
Authors: Mark A Rodrigues; Neshika Samarasekera; Christine Lerpiniere; Catherine Humphreys; Mark O McCarron; Philip M White; James A R Nicoll; Cathie L M Sudlow; Charlotte Cordonnier; Joanna M Wardlaw; Colin Smith; Rustam Al-Shahi Salman Journal: Lancet Neurol Date: 2018-01-10 Impact factor: 44.182
Authors: Xiaomeng Xu; Shu Huang; YuE Zeng; Yulan Feng; Dongqi Yue; Fanxia Shen; Yang Gao; Bei Zhang; Yang Yang; Lin Gu; Yi Fu Journal: Front Aging Neurosci Date: 2022-03-08 Impact factor: 5.750
Authors: Maaike P Cliteur; Lotte Sondag; Axel Wolsink; Ingeborg Rasing; F J A Meijer; Wilmar M T Jolink; Marieke J H Wermer; Catharina J M Klijn; Floris H B M Schreuder Journal: Front Neurol Date: 2022-07-29 Impact factor: 4.086
Authors: James Jm Loan; Caoimhe Kirby; Katherine Emelianova; Owen R Dando; Michael Tc Poon; Leisan Pimenova; Giles E Hardingham; Barry W McColl; Catharina Jm Klijn; Rustam Al-Shahi Salman; Floris Hbm Schreuder; Neshika Samarasekera Journal: J Neurol Neurosurg Psychiatry Date: 2021-08-06 Impact factor: 10.154